<p>Study will evaluate senolytics — drugs that clear defective ‘zombie’ cells Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 30, 2023) — A clinical trial conducted at UT Health San Antonio aims to “stomp” out Alzheimer’s disease. Clearing old, damaged “zombie” cells from the brain may be one way to do it. The study, called […]</p>
Share This Story
<p>Promoting improved patient care, community learning, social impact Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Jan. 30, 2023 – The UT Health San Antonio School of Dentistry has entered into partnership with the Straumann Group, a world leader in implant components and digital equipment and services, to establish a patient treatment center housing a comprehensive […]</p>
Share This Story
<p>Thursday, January 26, 2023: Her Royal Highness Princess Maha Chakri Sirindhorn of Thailand, representing His Majesty the King Rama X Vajiralongkorn, presents the Prince Mahidol Award for 2022 in the field of medicine to Ralph A. DeFronzo, MD, of UT Health San Antonio and University Health. The presentation took place at the Chakri Throne Hall […]</p>
Share This Story
<p>Basic science generates new drug for treating glioblastoma, the deadliest cancer Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Ryan Schoensee, 210-458-6054, ryan.schoensee@utsa.edu SAN ANTONIO (Jan. 24, 2023) — Glioblastoma multiforme (GBM) is an aggressive brain cancer associated with the worst overall survival rates among all human cancers. Only 65% of GBM patients live one year past diagnosis […]</p>
Share This Story
<p>Deep brain stimulation, continuous levodopa infusion among topics Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 25, 2023) — Four fellowship-trained movement disorders neurologists from UT Health San Antonio will give talks Friday (Jan. 27) at the Parkinson’s Foundation Tri-State Symposium. These physicians will discuss the newest developments in research and clinical trials of Parkinson’s […]</p>
Share This Story
<p>Study of jaw-joint sensory neurons aimed at creating safer pain treatment Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO, Jan. 23, 2023 – The UT Health San Antonio School of Dentistry has received a major five-year, $9.8 million grant from the National Institutes of Health to discover how sensory neurons in the jaw joint and mastication […]</p>
Share This Story
<p> Drug target that revs up energy expenditure, reduces appetite identified Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 20, 2023) — A drug that promotes energy expenditure in the body while suppressing appetite could be a powerful weight loss therapy. Researchers at The University of Texas Health Science Center at San Antonio, the Second […]</p>
Share This Story
<p>Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu With more than 50 studies, departments and centers, the Center for Brain Health at The University of Texas Health Science Center at San Antonio will be home to the institution’s many brain health initiatives. For a complete overview of these vital programs, visit https://advancingbrainhealth.org/. Recently, UT Health San Antonio received […]</p>
Share This Story
<p>Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Statement from the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases at UT Health San Antonio about a timely topic in the news: The U.S. Food and Drug Administration on Friday, Jan. 6, 2023, approved lecanemab, a drug that targets the basic pathophysiology of Alzheimer’s disease. The FDA action is […]</p>
Share This Story
<p>16-member panel makes evidence-based recommendations to the nation’s primary care providers about services such as colonoscopy. Contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu SAN ANTONIO (Jan. 10, 2023) — Joel Tsevat, MD, MPH, professor of medicine at The University of Texas Health Science Center at San Antonio, has been appointed to the U.S. Preventive Services Task Force. […]</p>
Share This Story